Group One Trading’s Strongbridge Biopharma plc. SBBP Stock Holding History

Group One Trading’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-115,500	Closed	-$236K	–	9232
2021 Q3	$236K	Buy	115,500 +4,000	+4%	+$9.31K	﹤0.01%	5002
2021 Q2	$331K	Sell	111,500 -9,200	-8%	-$24.3K	﹤0.01%	4683
2021 Q1	$333K	Buy	+120,700	New	+$364K	﹤0.01%	4479
2020 Q4	–	Sell	-600	Closed	-$1K	–	7253
2020 Q3	$1K	Buy	+600	New	+$2.02K	﹤0.01%	5995
2020 Q2	–	Sell	-500	Closed	-$1K	–	6406
2020 Q1	$1K	Buy	+500	New	+$1.3K	﹤0.01%	5145
2019 Q1	–	Sell	-3,900	Closed	-$17K	–	5600
2018 Q4	$17K	Sell	3,900 -500	-11%	-$2.44K	﹤0.01%	4098
2018 Q3	$21K	Buy	+4,400	New	+$22.5K	﹤0.01%	4378

Group One Trading's SBBP Position: Q4 2020 in Review

Group One Trading sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2020, closing a stake of 5,000 shares — an estimated $12K sold.

Group One Trading first reported a position in SBBP in Q3 2020 and held it in 1 quarter. The position peaked at $11K in Q3 2020. 71 funds tracked by Wall St. Rank hold SBBP as of Q4 2020.

Group One Trading reported no remaining Strongbridge Biopharma plc. position as of Q4 2020 after selling out during the quarter.
Group One Trading sold 5,000 Strongbridge Biopharma plc. shares in Q4 2020, an estimated $12K.
Group One Trading first reported a position in Strongbridge Biopharma plc. in Q3 2020 and held it in 1 quarter.
Group One Trading's Strongbridge Biopharma plc. position peaked at $11K in Q3 2020.
71 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2020.

Based on Group One Trading's 13F filing for Q4 2020, filed 10 Feb 2021.